Kayne Anderson Rudnick Investment Management
LGND icon

Kayne Anderson Rudnick Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,879
Closed -$1.75M – 328
2015
Q2 		$1.75M Hold
27,879
– – 0.03% 224
2015
Q1 		$1.34M Hold
27,879
– – 0.02% 235
2014
Q4 		$925K Hold
27,879
– – 0.02% 253
2014
Q3 		$817K Hold
27,879
– – 0.01% 255
2014
Q2 		$1.08M Buy
+27,879
New +$1.13M 0.02% 239

Other funds holding LGND

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's LGND Position: Q3 2015 in Review

Kayne Anderson Rudnick Investment Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2015, closing a stake of 27,879 shares — an estimated $1.75M sold.

Kayne Anderson Rudnick Investment Management first reported a position in LGND in Q2 2014 and held it in 5 quarters. The position peaked at $1.75M in Q2 2015. 203 funds tracked by Wall St. Rank hold LGND as of Q3 2015.

  • Kayne Anderson Rudnick Investment Management reported no remaining Ligand Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 27,879 Ligand Pharmaceuticals shares in Q3 2015, an estimated $1.75M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Ligand Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Kayne Anderson Rudnick Investment Management's Ligand Pharmaceuticals position peaked at $1.75M in Q2 2015.
  • 203 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2015.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2015, filed 6 Nov 2015.